Business
Intelligence for founders, operators, and investors building sustainable cannabis ventures.
Business · page 5
- Cultivation
De-Risking the Future: What’s Holding Traditional Industry Back from Cannabis Investment?
Nearly a decade after the inception of what we would now consider the ‘global cannabis industry’, Prohibition Partners forecasts its total worth to be around $40bn in 2025, already larger than the entire global recorded music industry.
- Industry Trends
Deals, Courts and Coalition Splits: Germany’s Cannabis Market Braces for Change
It’s now five months since the German Federal Cabinet adopted draft amendments to its pivotal Medizinal-Cannabisgesetzes (MedCanG) bill, and its finalisation is expected in the coming weeks.
- Cultivation
Business Brief: Canify and MG Health Announce Merger
German pharmaceutical cannabis company Canify AG and African medical cannabis cultivator MG Health Limited have announced a planned merger, marking yet another M&A deal in a market widely expected to see an incoming wave of consolidation.
- Retail & Brands
Canada’s Cannabis Retail Market Reaches C$5.5bn in 2024/25, But Growth Slowing
Canadian adult-use cannabis sales reached C$5.5 billion in the fiscal year ending 31 March 2025, a 6.1% increase on the prior year, according to new data from Statistics Canada, though the pace of growth continued to slow for the third consecutive year.
- Patient Access
Patient Protect Launches to Support UK Medical Cannabis Patients Facing Discrimination
A new UK-wide service supporting medical cannabis patients who face discrimination has launched, as the private sector continues to fill gaps left by the absence of systematic government support.
- Industry Trends
Germany’s Post-CanG Import Surge Loses Steam as Q4 Growth Stalls
Germany’s imports for 2025 surpassed 200 tonnes for the first time, exceeding the country’s already revised import quota for the second time in a year.
- Industry Trends
The Scramble for Europe
Last month, the German cannabis market saw its most significant consolidation deal to date, as Canadian heavyweight Organigram announced plans to acquire Sanity Group in a deal worth up to €250m.
- Prescribers & Clinics
Evidena Care Launches Switzerland’s First Integrated Medical Cannabis Market Comparison Platform
Evidena Care, one of Switzerland’s leading specialised telemedicine providers for medical cannabis, has announced the launch of a nationwide online comparison platform for prescription-based medical cannabis products.
- M&A Activity
Curaleaf Laboratories and Sanity Group Announce Partnership to Advance Medical Cannabis Innovation in the UK
Curaleaf Laboratories, one of the UK-leading pharmaceutical-grade medical cannabis manufacturers, is delighted to announce a partnership with Berlin-based Sanity Group, a European life science company focused on cannabinoids and wellbeing products.
- Press releases
Why We Built PPX: From Advocacy to Growth
In 2017, when we launched Prohibition Partners, we set out with the goal to change the conversation around cannabis.
- Investment & Finance
Business Brief: Safe Harbor Capitalises on Rescheduling Momentum with Financial Ecosystem Offering
Cannabis fintech Safe Harbor Financial is positioning itself to capitalise on the regulatory tailwinds created by federal rescheduling, launching new service partnerships and renegotiating core banking agreements in a bid to fill the severe financial infrastructure gap in the US cannabis industry.
- M&A Activity
Business Brief: Argent Biopharma’s Revenues Drop, Outgoings Rise Ahead of AusCann Deal
Argent Biopharma, formerly MGC Pharmaceuticals, has entered 2026 in a precarious financial position, according to its recently published quarterly figures.
